Expiring federal contract · order under a contract vehicle
75H70726F80013 — Fisher Scientific Company L.L.C.
Department of Health and Human Services · Indian Health Service
- Contract / PIID
- 75H70726F80013
- Incumbent
- Fisher Scientific Company L.L.C.
- Incumbent UEI
- F5TEGZ32EJ38
- Current end date
- April 30, 2027
- Potential total value
- $610,000
- Obligated
- $610,000
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Set-aside
- Not stated
- Start date
- May 1, 2026
- Place of performance
- NM
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
AAO/AAIHS- LABORATORY REAGENTS/SUPPLIES.
Likely rebid window (estimate)
- Sources Sought / RFI: about Apr 2026 – Oct 2026 (6–12 months before the end date)
- RFP: about Dec 2026 – Feb 2027 (2–4 months before the end date)
Between the estimated Sources Sought and RFP windows.
This is an order under contract vehicle 36F79718D0395. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325413)
- 75H71025P00975 — Becton, Dickinson And Company · ends November 30, 2026 · $103K
- 75H71226F28022 — Cepheid · ends January 11, 2027 · $460K
- 75N90026P00079 — Werfen USA LLC · ends January 31, 2027 · $170K
- 75H71226F28026 — Cepheid · ends February 7, 2027 · $272K
- 75H71226F28010 — Biomerieux INC · ends February 26, 2027 · $240K
- 75H70722P00094 — Cepheid · ends February 28, 2027 · $2.8M
- 75H70723F80016 — Abbott Laboratories INC. · ends February 28, 2027 · $310K
- 75H71025F80116 — Roche Diabetes Care INC · ends March 31, 2027 · $244K
- 75H71226F28027 — Cepheid · ends April 14, 2027 · $600K
- 75A50123C00036 — Siro Diagnostics, INC. · ends May 1, 2027 · $28M